Solid Biosciences Inc. — Director's Dealing 2018

Jul 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-07-25

Reporting Person: Freed Martin I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-25	Director Stock Option
(Right to Buy)	$37.89	A	3669	Acquired	2028-07-25	Common Stock (3669)	Direct

Footnotes

F1: This option was granted on July 25, 2018 and vests as to one-third of the total number of shares on each of the next three anniversaries of the grant date.